At present, information on the serum levels of pituitary, gonadal, thyroid hormones, and endocrine disruptors in Nigerian women with ER-, PR-, HER-2-positive (+) and negative (−) breast cancers are sparse. This evidence concerns the gene ESR1 and breast cancer.